Technology
Health
Biotechnology

Phio Pharmaceutical

$0.4559
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0306 (-6.72%) Today
+$0.0309 (7.27%) After Hours

Why Robinhood?

You can buy or sell PHIO and other stocks, options, ETFs, and crypto commission-free!

About

Phio Pharmaceuticals Corp. Common Stock, also called Phio Pharmaceutical, is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Read More Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Employees
15
Headquarters
Marlborough, Massachusetts
Founded
2011
Market Cap
2.03M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
639.60K
High Today
$0.464
Low Today
$0.425
Open Price
$0.464
Volume
396.50K
52 Week High
$5.16
52 Week Low
$0.27

Collections

Technology
Health
Biotechnology
Medical
Therapy
US
North America

Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.11 per share
Actual
Expected Mar 29, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.